Neuphoria Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Neuphoria Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- NEUP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001191070
Board of directors
-
Aaron Ngoc Dung Weaver · DirectorSince 2024
-
Alan Fisher · DirectorSince 2024
-
David Ian Wilson · DirectorSince 2024
-
Jane Ryan · DirectorSince 2024
-
Peter Miles Winston Davies · DirectorSince 2024
-
Spyros Papapetropoulos · Director · President and CEOSince 2024
Chief executives
Spyros Papapetropoulos
· Chief Executive Officer
Since July 2024
Board connections
2 of this board's directors also sit on 2 other boards.
- via Aaron Ngoc Dung Weaver
- via Spyros Papapetropoulos
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $3,285,025
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2025 | Lynx1 Capital Management LP 10% owner | Open-market purchase | +639,110 | $5.14 | $3,285,025 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.